These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 26315451)

  • 61. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
    Dörner T; Posch MG; Li Y; Petricoul O; Cabanski M; Milojevic JM; Kamphausen E; Valentin MA; Simonett C; Mooney L; Hüser A; Gram H; Wagner FD; Oliver SJ
    Ann Rheum Dis; 2019 May; 78(5):641-647. PubMed ID: 30826774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessing health-related quality of life in primary Sjögren's syndrome-The PSS-QoL.
    Lackner A; Stradner MH; Hermann J; Unger J; Stamm T; Graninger WB; Dejaco C
    Semin Arthritis Rheum; 2018 Aug; 48(1):105-110. PubMed ID: 29395257
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cognitive dysfunction in Sjögren's syndrome using the Montreal Cognitive Assessment Questionnaire and the Automated Neuropsychological Assessment Metrics: A cross-sectional study.
    Riega-Torres JCL; Treviño-Castro MA; Hernandez-Galarza IJ; Garza-Martinez MJ; Vera-Pineda R; Cardenas-de la Garza JA; Rodriguez-de la Garza P; Skinner-Taylor CM; Galarza-Delgado DA
    Int J Rheum Dis; 2020 Aug; 23(8):1019-1023. PubMed ID: 32608054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The rs3771863 single nucleotide polymorphism of the TACR1 gene is associated to a lower risk of sicca syndrome in fibromyalgia patients.
    Rodriguez-Rodriguez L; Ramón Lamas J; Abásolo L; Baena S; Olano-Martin E; Collado A; Rivera J; Fernández-Gutiérrez B
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S33-40. PubMed ID: 25786041
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
    Liu X; Li X; Li X; Li Z; Zhao D; Liu S; Zhang M; Zhang F; Zhu P; Chen J; Wei W; Lin B; Zhou Y; Chen J; Pang Y; Zhang L; Sun X; Yu Z; Jia Y; Wang J; Sun W; Chiu F; Pang L; Wang G
    Clin Rheumatol; 2019 Mar; 38(3):657-664. PubMed ID: 30280368
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ; Kelder JC
    Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.
    Baer AN; Gottenberg JE; St Clair EW; Sumida T; Takeuchi T; Seror R; Foulks G; Nys M; Mukherjee S; Wong R; Ray N; Bootsma H
    Ann Rheum Dis; 2021 Mar; 80(3):339-348. PubMed ID: 33168545
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disease phenotype and diagnostic delay in Saudi patients with primary Sjögren's syndrome: An exploratory cross-sectional study.
    Omair MA; AlQahtani BS; AlHamad EH; Tashkandy YA; Othman NS; AlShahrani KA; Paramasivam MP; AlEnzi F; Halwani R; Daghestani MH
    Saudi Med J; 2021 Apr; 42(4):405-410. PubMed ID: 33795496
    [TBL] [Abstract][Full Text] [Related]  

  • 69. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) and Other Patient-Reported Outcomes in the Assessment of Glandular Dysfunction in Primary Sjögren's Syndrome.
    Ture HY; Kim NR; Nam EJ
    Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895373
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?
    Baldini C; Delle Sedie A; Luciano N; Pepe P; Ferro F; Talarico R; Tani C; Mosca M
    Rheumatol Int; 2014 Aug; 34(8):1159-64. PubMed ID: 24097207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical determinants of vaginal dryness in patients with primary Sjögren's syndrome.
    Farenhorst CA; de Wolff L; Arends S; van Nimwegen JF; Kroese FGM; Verstappen GM; Bootsma H
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):73-79. PubMed ID: 34665706
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acupuncture for Primary Sjögren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial.
    Jiang Q; Zhang H; Pang R; Chen J; Liu Z; Zhou X
    BMC Complement Altern Med; 2017 Jan; 17(1):61. PubMed ID: 28103850
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome.
    Balarini GM; Zandonade E; Tanure L; Ferreira GA; Sardenberg WM; Serrano ÉV; Dias CC; Navarro TP; Nordal HH; Mydel PM; Brun JG; Brokstad KA; Gerdts E; Jonsson R; Valim V
    Clin Exp Rheumatol; 2016; 34(6):1006-1012. PubMed ID: 27749218
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.
    Jülich M; Kanne AM; Sehnert B; Budweiser S; Voll RE; Kollert F
    Clin Rheumatol; 2018 Sep; 37(9):2361-2366. PubMed ID: 29858711
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Childhood-onset primary Sjögren's syndrome in a tertiary center in China: clinical features and outcome.
    Gong Y; Liu H; Li G; Zhang T; Li Y; Guan W; Zeng Q; Lv Q; Zhang X; Yao W; Shi Y; Xu H; Sun L
    Pediatr Rheumatol Online J; 2023 Jan; 21(1):11. PubMed ID: 36707855
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Depression is the most significant independent predictor of fatigue in patients with primary Sjögren's syndrome.
    Ayar K; Kasapoğlu Aksoy M; Dilara Hattatoğlu T; Yeşil B
    Arch Rheumatol; 2023 Sep; 38(3):375-386. PubMed ID: 38046240
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Spanish version of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia: reliability and validity assessment.
    Casanueva B; García-Fructuoso F; Belenguer R; Alegre C; Moreno-Muelas JV; Hernández JL; Pina T; González-Gay MÁ
    Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S55-8. PubMed ID: 26752202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Depression in primary Sjögren's syndrome: a systematic review and meta-analysis.
    Cui Y; Li L; Yin R; Zhao Q; Chen S; Zhang Q; Shen B
    Psychol Health Med; 2018 Feb; 23(2):198-209. PubMed ID: 28621153
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
    Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
    Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chronic widespread pain in the spectrum of rheumatological diseases.
    Atzeni F; Cazzola M; Benucci M; Di Franco M; Salaffi F; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):165-71. PubMed ID: 22094193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.